Page last updated: 2024-08-24

lamivudine and Immunologic Deficiency Syndromes

lamivudine has been researched along with Immunologic Deficiency Syndromes in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berg, CL; Coffin, CS; Curry, MP; Dove, LM; Nissen, NN; Ragni, M; Regenstein, FG; Roland, ME; Sherman, KE; Stock, PG; Terrault, NA1
Chen, JX; Chen, Y; Li, CZ; Liang, XS; Song, Y; Wan, MB1

Other Studies

2 other study(ies) available for lamivudine and Immunologic Deficiency Syndromes

ArticleYear
Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2010, Volume: 10, Issue:5

    Topics: Adult; Aged; Antiviral Agents; Graft Survival; Hepatitis; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Immunoglobulins; Immunologic Deficiency Syndromes; Infections; Lamivudine; Liver Cirrhosis; Liver Failure; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Secondary Prevention; Treatment Outcome; Virus Diseases; Viruses

2010
[Therapeutic and preventive activities of lamivudine on HBV re-activation in HBV carriers with immunodeficiency].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2005, Volume: 13, Issue:5

    Topics: Adult; Carrier State; Female; Hepatitis B, Chronic; Humans; Immunologic Deficiency Syndromes; Lamivudine; Male; Middle Aged; Secondary Prevention

2005